PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17166729-1	2007	Tetracyclines inhibit matrix metalloproteinases (MMPs) and reduce infarction volume following cerebral ischemia.	Tetracyclines	0-13	matrix metallopeptidase 2	Rattus norvegicus	49-53	
15353401-1	2005	Tetracyclines exhibit significant anti-inflammatory properties, inhibit matrix metalloproteinases (MMPs), and are protective in models of ischemia-reperfusion injury (IRI).	Tetracyclines	0-13	matrix metallopeptidase 2	Rattus norvegicus	99-103	
21843641-1	2011	INTRODUCTION: Beyond their decades of long use as broad-spectrum antibiotics, tetracyclines and their derivatives have been shown to exhibit non-antimicrobial properties including their ability to interact with matrix metalloproteinases (MMP), tissue inhibitors of MMPs, growth factors and cytokines.	Tetracyclines	78-91	matrix metallopeptidase 2	Rattus norvegicus	238-241	
21843641-1	2011	INTRODUCTION: Beyond their decades of long use as broad-spectrum antibiotics, tetracyclines and their derivatives have been shown to exhibit non-antimicrobial properties including their ability to interact with matrix metalloproteinases (MMP), tissue inhibitors of MMPs, growth factors and cytokines.	Tetracyclines	78-91	matrix metallopeptidase 2	Rattus norvegicus	265-269